Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $698.76 | 70 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $285.13 | 46 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $190.91 | 2 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $90.79 | 15 | $0 (2017) |
| Braintree Laboratories, Inc. | $52.09 | 2 | $0 (2018) |
| AbbVie Inc. | $33.95 | 2 | $0 (2021) |
| Celgene Corporation | $26.32 | 2 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $19.57 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.74 | 1 | Celgene Corporation ($13.74) |
| 2021 | $34.52 | 2 | AbbVie Inc. ($21.94) |
| 2019 | $51.92 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($51.92) |
| 2018 | $447.63 | 42 | Takeda Pharmaceuticals U.S.A., Inc. ($233.21) |
| 2017 | $150.95 | 18 | Takeda Pharmaceuticals America, Inc. ($90.79) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/18/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: Neuroscience | ||||||
| 09/09/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Neuroscience | ||||||
| 07/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: Lower GI | ||||||
| 02/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Lower GI | ||||||
| 01/31/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: Lower GI | ||||||
| 01/31/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: Lower GI | ||||||
| 01/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Lower GI | ||||||
| 01/04/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Lower GI | ||||||
| 01/03/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Lower GI | ||||||
| 12/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Lower GI | ||||||
| 12/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Lower GI | ||||||
| 11/29/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Lower GI | ||||||
| 11/15/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: Gout/Rheumatology | ||||||
| 11/01/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Lower GI | ||||||
| 10/31/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Lower GI | ||||||
| 10/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Lower GI | ||||||
| 10/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: Lower GI | ||||||
| 10/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Lower GI | ||||||
| 10/04/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Lower GI | ||||||
| 09/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Lower GI | ||||||
| 09/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: Gout/Rheumatology | ||||||
| 09/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Lower GI | ||||||
| 08/30/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Lower GI | ||||||
| 08/02/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 343 | 397 | $444,756 | $50,922 |
| 2022 | 9 | 491 | 626 | $600,345 | $76,460 |
| 2021 | 11 | 485 | 628 | $486,244 | $77,578 |
| 2020 | 10 | 461 | 649 | $476,169 | $72,840 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 186 | $128,154 | $20,403 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $79,779 | $11,867 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $62,998 | $4,701 | 7.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $53,118 | $4,661 | 8.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $75,432 | $4,047 | 5.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $35,347 | $3,248 | 9.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 17 | $9,928 | $1,995 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 192 | $132,288 | $21,295 | 16.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 167 | $76,820 | $16,027 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 91 | 91 | $83,447 | $12,888 | 15.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $26,370 | $5,614 | 21.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 21 | $57,099 | $5,290 | 9.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $57,204 | $5,146 | 9.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $75,113 | $4,560 | 6.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $86,208 | $4,431 | 5.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 18 | $5,796 | $1,209 | 20.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 170 | $78,200 | $16,786 | 21.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 128 | $61,322 | $15,330 | 25.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 75 | 75 | $55,200 | $12,062 | 21.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 53 | 55 | $48,345 | $10,701 | 22.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 16 | 16 | $43,504 | $4,071 | 9.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 42 | 42 | $75,432 | $3,550 | 4.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 20 | 20 | $40,860 | $3,462 | 8.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 50 | $16,100 | $3,444 | 21.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 23 | 25 | $14,600 | $2,944 | 20.2% |
About Dr. Robert Brunner, MD
Dr. Robert Brunner, MD is a Gastroenterology healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801979828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Brunner, MD has received a total of $698.76 in payments from pharmaceutical and medical device companies, with $13.74 received in 2022. These payments were reported across 70 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($698.76).
As a Medicare-enrolled provider, Brunner has provided services to 1,780 Medicare beneficiaries, totaling 2,300 services with total Medicare billing of $277,800. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New Hyde Park, NY
- Active Since 10/23/2006
- Last Updated 09/24/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1801979828
Products in Payments
- Amitiza (Drug) $363.97
- RELISTOR (Drug) $100.00
- XIFAXAN (Drug) $90.91
- SUPREP (Drug) $52.09
- ZEPOSIA (Drug) $26.32
- UBRELVY (Drug) $21.94
- LINZESS (Drug) $19.57
- Humira (Biological) $12.01
- Uloric (Drug) $11.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New Hyde Park
Dr. Ian Storch, Do, DO
Gastroenterology — Payments: $134,923
Anjali Mone, M.d, M.D
Gastroenterology — Payments: $33,047
Lev Ginzburg, M.d, M.D
Gastroenterology — Payments: $26,382
Dr. Nilesh Mehta, Mbbs, Md, MBBS, MD
Gastroenterology — Payments: $20,236
Tai-Ping Lee, Md, MD
Gastroenterology — Payments: $14,910
Dr. Asadur Miah, Do, DO
Gastroenterology — Payments: $6,089